CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 214 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,895,524 | -23.3% | 142,980 | -37.3% | 0.02% | -25.0% |
Q2 2023 | $5,076,649 | +3.0% | 228,167 | +0.3% | 0.02% | -9.1% |
Q1 2023 | $4,928,646 | +1197.6% | 227,546 | +1116.7% | 0.02% | +1000.0% |
Q4 2022 | $379,838 | -20.2% | 18,702 | +0.8% | 0.00% | -33.3% |
Q3 2022 | $476,000 | +163.0% | 18,555 | +143.1% | 0.00% | +200.0% |
Q2 2022 | $181,000 | +18.3% | 7,632 | +12.2% | 0.00% | 0.0% |
Q1 2022 | $153,000 | +112.5% | 6,805 | +87.8% | 0.00% | – |
Q4 2021 | $72,000 | +9.1% | 3,624 | +7.6% | 0.00% | -100.0% |
Q3 2021 | $66,000 | -9.6% | 3,368 | +1.1% | 0.00% | 0.0% |
Q2 2021 | $73,000 | -23.2% | 3,331 | -16.2% | 0.00% | 0.0% |
Q1 2021 | $95,000 | +1483.3% | 3,975 | +1706.8% | 0.00% | – |
Q4 2020 | $6,000 | +200.0% | 220 | +83.3% | 0.00% | – |
Q3 2020 | $2,000 | – | 120 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INGALLS & SNYDER LLC | 8,712,176 | $123,147,000 | 6.01% |
TANAKA CAPITAL MANAGEMENT INC | 74,139 | $1,048,000 | 3.38% |
S&T BANK/PA | 625,078 | $8,859,000 | 1.92% |
Parallel Advisors, LLC | 1,277,851 | $18,062,000 | 1.55% |
AJ WEALTH STRATEGIES, LLC | 595,828 | $8,422,000 | 1.11% |
Matarin Capital Management, LLC | 891,636 | $12,603,000 | 0.95% |
Capital Impact Advisors, LLC | 162,544 | $2,370,000 | 0.90% |
AMI ASSET MANAGEMENT CORP | 775,685 | $10,964,000 | 0.57% |
Birchview Capital, LP | 50,000 | $707,000 | 0.47% |
Zebra Capital Management LLC | 25,409 | $359,000 | 0.39% |